• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米兰标准、加利福尼亚大学旧金山分校标准以及终末期肝病模型评分作为挽救性肝移植的预测指标。

Milan criteria, University of California, San Francisco, criteria, and model for end-stage liver disease score as predictors of salvage liver transplantation.

作者信息

Zhang H-M, Jiang W-T, Pan C, Deng Y-L, Zheng H, Shen Z-Y

机构信息

Transplantation Department, First Central Clinical College of Tianjin Medical University, Tianjin First Central Hospital, Tianjin Key Laboratory of Organ Transplantation, Tianjin, People's Republic of China.

Transplantation Department, First Central Clinical College of Tianjin Medical University, Tianjin First Central Hospital, Tianjin Key Laboratory of Organ Transplantation, Tianjin, People's Republic of China.

出版信息

Transplant Proc. 2015 Mar;47(2):438-44. doi: 10.1016/j.transproceed.2014.10.046.

DOI:10.1016/j.transproceed.2014.10.046
PMID:25769587
Abstract

The selection criteria for salvage liver transplantation (SLT) candidates have not been previously established. A global analysis for the association between the criteria and prognosis is required. All of the adult patients who underwent liver transplantation with a diagnosis of hepatocellular carcinoma (HCC) from January 1, 2000, to December 31, 2011, were retrospectively analyzed. A total of 1,554 cases were involved, including 1,392 primary liver transplantation (PLT) and 162 SLT cases. All the cases were classified into 3 groups according to the Milan criteria combined with the University of California, San Francisco (UCSF), criteria, and significant differences were found between the 2 groups. The overall graft survival rate was lower in all cases of SLT than in PLT (P = .030). Within the Milan criteria, no significant difference in the graft survival rate was found between PLT and SLT. In a Cox regression analysis, the Model for End-Stage Liver Disease (MELD) score and tumor levels graded according to the Milan/UCSF criteria were found to be independent risk factors for the graft survival rate. Receiver operating characteristic (ROC) curves were generated by the fatality risk values calculated by means of the Cox model and the 1-year graft survival rates of all the patients and of the SLT patients. The areas under the ROC curves were 0.922 and 0.935, respectively. Compared with PLT, the global graft survival rate of SLT was compromised. The MELD score and Milan/UCSF criteria were effective in predicting the prognosis of PLT and SLT. Therefore, when the recurrent lesions of HCC are within the Milan criteria, SLT can be performed with a good prognosis.

摘要

挽救性肝移植(SLT)候选者的选择标准此前尚未确立。需要对这些标准与预后之间的关联进行全面分析。对2000年1月1日至2011年12月31日期间接受肝移植且诊断为肝细胞癌(HCC)的所有成年患者进行了回顾性分析。共纳入1554例病例,包括1392例初次肝移植(PLT)和162例SLT病例。所有病例根据米兰标准联合加利福尼亚大学旧金山分校(UCSF)标准分为3组,两组之间存在显著差异。所有SLT病例的总体移植物存活率低于PLT(P = 0.030)。在米兰标准范围内,PLT和SLT的移植物存活率无显著差异。在Cox回归分析中,终末期肝病模型(MELD)评分和根据米兰/UCSF标准分级的肿瘤水平被发现是移植物存活率的独立危险因素。通过Cox模型计算的死亡风险值以及所有患者和SLT患者的1年移植物存活率生成了受试者操作特征(ROC)曲线。ROC曲线下面积分别为0.922和0.935。与PLT相比,SLT的总体移植物存活率受到影响。MELD评分和米兰/UCSF标准在预测PLT和SLT的预后方面有效。因此,当HCC复发灶在米兰标准范围内时,可进行SLT且预后良好。

相似文献

1
Milan criteria, University of California, San Francisco, criteria, and model for end-stage liver disease score as predictors of salvage liver transplantation.米兰标准、加利福尼亚大学旧金山分校标准以及终末期肝病模型评分作为挽救性肝移植的预测指标。
Transplant Proc. 2015 Mar;47(2):438-44. doi: 10.1016/j.transproceed.2014.10.046.
2
Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection.UCSF 标准范围内肝切除术后复发肝细胞癌的挽救性肝移植。
PLoS One. 2012;7(11):e48932. doi: 10.1371/journal.pone.0048932. Epub 2012 Nov 8.
3
Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.肿瘤生长速率可预测超出米兰或加州大学旧金山分校标准的患者肝移植后肝细胞癌的复发情况。
Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043.
4
Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk.肝切除术后复发性肝细胞癌的挽救性肝移植:米兰标准的可行性及手术风险
Transplant Proc. 2008 Dec;40(10):3558-61. doi: 10.1016/j.transproceed.2008.03.175.
5
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?复发性肝细胞癌的治疗策略:挽救性移植、再次切除还是射频消融?
Liver Transpl. 2013 Apr;19(4):411-9. doi: 10.1002/lt.23605. Epub 2013 Mar 17.
6
Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.肝细胞癌患者的挽救性肝移植与原位肝移植对比
Ann Transplant. 2018 Aug 3;23:524-545. doi: 10.12659/AOT.908623.
7
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.根据肝移植术前和术后肿瘤特征的加州大学旧金山分校标准的影响:对479例等待时间短的肝癌登记患者的分析。
Liver Transpl. 2006 Dec;12(12):1761-9. doi: 10.1002/lt.20884.
8
Accuracy of Milan, University of California San Francisco, and Up-To-7 Criteria in Predicting Tumor Recurrence Following Deceased-Donor Liver Transplant in Patients With Hepatocellular Carcinoma.米兰标准、加利福尼亚大学旧金山分校标准和 Up-To-7 标准预测肝癌患者接受尸体供肝肝移植后肿瘤复发的准确性。
Exp Clin Transplant. 2020 Aug;18(4):463-469. doi: 10.6002/ect.2017.0288. Epub 2018 Aug 6.
9
A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.一种新型预后列线图可准确预测肝移植后肝细胞癌复发:对865例连续肝移植受者的分析
J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025. Epub 2014 Dec 27.
10
Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.影响肝细胞癌肝移植生存因素的研究:来自布达佩斯的单中心经验
Transplant Proc. 2015 Sep;47(7):2201-6. doi: 10.1016/j.transproceed.2015.07.026.

引用本文的文献

1
Clinical Practice Guidelines For the Management of Hepatocellular Carcinoma: A Systematic Review.肝细胞癌管理临床实践指南:系统评价。
J Gastrointest Cancer. 2024 Mar;55(1):318-331. doi: 10.1007/s12029-023-00961-0. Epub 2023 Jul 22.
2
Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges.复发性肝细胞癌的外科治疗:现状与挑战
World J Gastrointest Surg. 2023 Apr 27;15(4):544-552. doi: 10.4240/wjgs.v15.i4.544.
3
MTM-HCC at Previous Liver Resection as a Predictor of Overall Survival in Salvage Liver Transplantation.
既往肝切除时的MTM-HCC作为挽救性肝移植总体生存的预测指标
Dig Dis Sci. 2023 Jun;68(6):2768-2777. doi: 10.1007/s10620-023-07857-w. Epub 2023 Feb 15.
4
Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.肝切除术后复发性肝细胞癌的手术策略:当前证据综述
Cancers (Basel). 2023 Jan 13;15(2):508. doi: 10.3390/cancers15020508.
5
Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy.复发性肝细胞癌治疗策略的系统评价:挽救性肝移植还是根治性局部治疗。
Medicine (Baltimore). 2019 Feb;98(8):e14498. doi: 10.1097/MD.0000000000014498.
6
Resection versus transplantation for hepatocellular carcinoma exceeding Milan criteria within increasing donor shortage.在供体日益短缺的情况下,肝细胞癌超出米兰标准后的肝切除术与肝移植术对比研究
Hepatobiliary Surg Nutr. 2017 Aug;6(4):280-283. doi: 10.21037/hbsn.2017.03.14.
7
Milan criteria and its expansions in liver transplantation for hepatocellular carcinoma.米兰标准及其在肝细胞癌肝移植中的扩展。
Hepatobiliary Surg Nutr. 2016 Dec;5(6):498-502. doi: 10.21037/hbsn.2016.12.09.
8
Bi-directional roles of IRF-1 on autophagy diminish its prognostic value as compared with Ki67 in liver transplantation for hepatocellular carcinoma.与Ki67相比,IRF-1在自噬中的双向作用降低了其在肝细胞癌肝移植中的预后价值。
Oncotarget. 2016 Jun 21;7(25):37979-37992. doi: 10.18632/oncotarget.9365.